Marshall Wace’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Marshall Wace’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-19,037	Closed	-$223K	–	2380
2020 Q3	$223K	Buy	+19,037	New	+$253K	﹤0.01%	1438
2020 Q2	–	Sell	-5,188	Closed	-$48K	–	2105
2020 Q1	$48K	Buy	+5,188	New	+$72.5K	﹤0.01%	1442
2019 Q4	–	Sell	-1,025	Closed	-$17K	–	2226
2019 Q3	$17K	Buy	+1,025	New	+$14.2K	﹤0.01%	1605
2019 Q2	–	Sell	-68,779	Closed	-$1.19M	–	2036
2019 Q1	$1.19M	Buy	+68,779	New	+$1.09M	0.01%	882
2018 Q4	–	Sell	-80,435	Closed	-$1.3M	–	1901
2018 Q3	$1.3M	Buy	+80,435	New	+$1.15M	0.01%	759

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace's OXFD Position: Q4 2020 in Review

Marshall Wace sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 19,037 shares — an estimated $223K sold.

Marshall Wace first reported a position in OXFD in Q3 2018 and held it in 5 quarters. The position peaked at $1.3M in Q3 2018. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

Marshall Wace reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
Marshall Wace sold 19,037 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $223K.
Marshall Wace first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2018 and held it in 5 quarters.
Marshall Wace's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.3M in Q3 2018.
60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.